These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 8369375)

  • 1. Selection designs for pilot studies based on survival.
    Liu PY; Dahlberg S; Crowley J
    Biometrics; 1993 Jun; 49(2):391-8. PubMed ID: 8369375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing an experimental agent to a standard agent: relative merits of a one-arm or randomized two-arm Phase II design.
    Taylor JM; Braun TM; Li Z
    Clin Trials; 2006; 3(4):335-48. PubMed ID: 17060208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sample size determination for comparing several survival curves with unequal allocations.
    Halabi S; Singh B
    Stat Med; 2004 Jun; 23(11):1793-815. PubMed ID: 15160409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and endpoints of clinical trials in hepatocellular carcinoma.
    Llovet JM; Di Bisceglie AM; Bruix J; Kramer BS; Lencioni R; Zhu AX; Sherman M; Schwartz M; Lotze M; Talwalkar J; Gores GJ;
    J Natl Cancer Inst; 2008 May; 100(10):698-711. PubMed ID: 18477802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A model to select regimens for phase III trials for patients with advanced-stage non-small cell lung cancer.
    Freidlin B; Breathnach OS; Johnson BE
    Clin Cancer Res; 2003 Mar; 9(3):917-22. PubMed ID: 12631588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel designs for multi-arm clinical trials with survival outcomes with an application in ovarian cancer.
    Royston P; Parmar MK; Qian W
    Stat Med; 2003 Jul; 22(14):2239-56. PubMed ID: 12854091
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picking the winners in a sea of plenty.
    Scher HI; Heller G
    Clin Cancer Res; 2002 Feb; 8(2):400-4. PubMed ID: 11839655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint modeling of progression-free survival and death in advanced cancer clinical trials.
    Dejardin D; Lesaffre E; Verbeke G
    Stat Med; 2010 Jul; 29(16):1724-34. PubMed ID: 20572123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysing sequential events in clinical trials.
    Salter A; Raab G; Day S
    Clin Trials; 2006; 3(5):421-30. PubMed ID: 17060216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cox regression methods for two-stage randomization designs.
    Lokhnygina Y; Helterbrand JD
    Biometrics; 2007 Jun; 63(2):422-8. PubMed ID: 17425633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-stage design for choosing among several experimental treatments and a control in clinical trials.
    Thall PF; Simon R; Ellenberg SS
    Biometrics; 1989 Jun; 45(2):537-47. PubMed ID: 2765637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing a decision-theoretic design in clinical trials: why and how?
    Palmer CR; Shahumyan H
    Stat Med; 2007 Nov; 26(27):4939-57. PubMed ID: 17582801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some design issues of strata-matched non-randomized studies with survival outcomes.
    Mazumdar M; Tu D; Zhou XK
    Stat Med; 2006 Dec; 25(23):3949-59. PubMed ID: 16596571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A note on P-values under group sequential testing and nonproportional hazards.
    Gillen DL; Emerson SS
    Biometrics; 2005 Jun; 61(2):546-51. PubMed ID: 16011703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sample size for two-stage studies with maintenance therapy.
    Feng W; Wahed AS
    Stat Med; 2009 Jul; 28(15):2028-41. PubMed ID: 19382105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized phase II trials with a prospective control.
    Jung SH
    Stat Med; 2008 Feb; 27(4):568-83. PubMed ID: 17573688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validity and efficiency of approximation methods for tied survival times in Cox regression.
    Hertz-Picciotto I; Rockhill B
    Biometrics; 1997 Sep; 53(3):1151-6. PubMed ID: 9333345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of factorial survival experiments.
    Slud EV
    Biometrics; 1994 Mar; 50(1):25-38. PubMed ID: 8086609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian design and analysis of two x two factorial clinical trials.
    Simon R; Freedman LS
    Biometrics; 1997 Jun; 53(2):456-64. PubMed ID: 9192445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of long-term survival: use of diagnostics and robust estimators with Cox's proportional hazards model.
    Valsecchi MG; Silvestri D; Sasieni P
    Stat Med; 1996 Dec; 15(24):2763-80. PubMed ID: 8981685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.